Fintel reports that on February 6, 2025, Wedbush initiated coverage of Bicara Therapeutics (NasdaqGM:BCAX) with a Outperform ...

Adicet Bio (NASDAQ:ACET – Get Free Report)‘s stock had its “neutral” rating reissued by investment analysts at HC Wainwright in a research note issued on Wednesday,Benzinga reports. A number of other ...

Dan Ives, Wedbush Securities managing director and global head of tech research, reacts to Amazon's first-quarter forecast. He speaks on "Bloomberg The Close." Amazon projected operating income of $14 ...

Revenue: Analysts tracked by FactSet expect $187.3 billion in revenue, up from $170.0 billion a year before. The FactSet consensus calls for 8.6% growth in North America revenue to $114.6 billion, 9.7 ...

Palantir trades at valuations such that the stock still looks richly valued even after hyperbolic growth in its business.

Amazon's earnings call is today at 5 pm ET. AMZN stock heads into the report up 8% YTD. Investors are focused on cloud demand ...

In a report released today, Robert Driscoll from Wedbush maintained a Buy rating on Kura Oncology (KURA – Research Report), with a price target ...

In many ways, these have been tough days for Tesla. Falling sales. Squeezed profit margins. Proposed changes in US government ...

Sutton Place Investors LLC lifted its stake in Alphabet Inc. (NASDAQ:GOOG – Free Report) by 12.3% in the fourth quarter, ...

Palantir Technologies shares soared to an all-time high Tuesday after the company's outlook blew past analysts' expectations on strong demand for AI.